Phase 2 trial of neoadjuvant docetaxel, oxaliplatin, and S‐1 for clinical stage III gastric or esophagogastric junction adenocarcinoma

BACKGROUND: Although perioperative treatment has been the standard of care for resectable gastric cancer in the West, postoperative adjuvant chemotherapy is still the standard in Japan. We conducted the first phase 2 trial to investigate the efficacy and safety of neoadjuvant docetaxel, oxaliplatin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurokawa, Yukinori, Kawase, Tomono, Takeno, Atsushi, Furukawa, Haruna, Yoshioka, Ryo, Saito, Takuro, Takahashi, Tsuyoshi, Shimokawa, Toshio, Eguchi, Hidetoshi, Doki, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043771/
https://www.ncbi.nlm.nih.gov/pubmed/36998295
http://dx.doi.org/10.1002/ags3.12632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043771/
https://www.ncbi.nlm.nih.gov/pubmed/36998295
http://dx.doi.org/10.1002/ags3.12632

Ejemplares similares